Study on Tumor-suppression Effect and Immunostimulatory Activity Caused by Ad-hIL-24 in H22 Hepatoma Mice

汪小华,缪竞诚,盛伟华,谢宇锋,杨吉成
2009-01-01
Abstract:Objective To study the tumor-suppressive effect and immunostimulatory activity caused by Ad-hIL-24 on H22 hepatoma mice. Methods The subcutaneous tumor models were established in 12 mouse with H22 hepatoma, and were randomly divided into 3 groups: PBS group, 5 -Fu group and Ad-hIL-24 group. Then PBS, 5-Fu (20μg/kg), Ad-hIL-24 (1×107pfu) were given, intra-tumor injections respectively. Additional 4 mice were taken as the controls. After 15 days, 16 mice were sacri- ficed and subcutaneous tumors in 12 H22 hepatoma mice were drawn out,thymuses and spleens of all mice were taken out. The weights of tumor were measured. The ratio of tumor-suppressione, the indexes of the thymus and spleen, the numbers of white blood cells, the number of lymphocytes, mononuclear cells and neutrophils were detected. Results Compared with PBS group, the ratio of tumor-suppression of Ad-hIL-24 and 5-Fu was 45.08% and 52.11%, respectively. Compared with 5-Fu group, Ad-hIL-24 enhanced the indexes of thymuses and spleens, the numbers of white blood cells and lymphocytes significantly (P0.05). The numbers of neutrophils infected with Ad-hIL-24 had significantly increased, compared with the control group (P0.05). Conclusion Ad-hIL-24 inhibits H22 hepatoma in mice and have no side effect on immune function.
What problem does this paper attempt to address?